Department of Botany, Faculty of Bio-Sciences, University of Barishal, Barishal, 8254, Bangladesh; Center for Gene Science, Hiroshima University, 1-4-2 Kagamiyama, Higashi-Hiroshima, Hiroshima, 739-8527, Japan; Department of Molecular Biotechnology, Graduate School of Integrated Sciences for Life, Hiroshima University, 1-3-1 Kagamiyama, Higashi-Hiroshima, Hiroshima, 739-8530, Japan.
Department of Botany, Faculty of Bio-Sciences, University of Barishal, Barishal, 8254, Bangladesh.
J Ethnopharmacol. 2022 Mar 1;285:114853. doi: 10.1016/j.jep.2021.114853. Epub 2021 Nov 23.
Indigenous knowledge of medicinal plants is an integral part of the primary health care (PHC) system in almost every society. For more than two centuries, Munda, a small ethnic group in Bangladesh, has lived around the Sundarbans, the world's largest mangrove forest. This mangrove is rich in biodiversity but is threatened by global climate change. Information on the therapeutic use of plants by Munda ethnic minorities remains completely unknown. Therefore, it needs urgent documentation.
The purpose of the study is (1) to search and compile data on the diversity of medicinal plants used by the Munda people for PHC needs, and (2) Quantitative analysis of these data to identify important medicinal plants and diseases related to treatment by this species.
We conducted repeated field surveys and interviews among 79 Munda informants to collect ethnobotanical data. Informants were selected through random sampling techniques and interviewed using an open and semi-structured questionnaire. We reported the primary (absolute) data as use reports (URs) with frequency citation (FC). The International Classification of Primary Care-2 (ICPC-2) was followed to categorize the therapeutic use of medicinal plants, and quantitative analysis was performed using the FC and informant consensus factor (ICF).
The present study explored and compiled a total of 3199 medicinal URs for 98 medicinal plant species to treat 132 ailment conditions under sixteen (16) ICPC-2 pathological groups. The highest URs (948) were noted for the digestive (D) group treated by 69 plant species, where the highest ICF value was measured for the social problem (Z) disease category (ICF: 1.00). Of the recorded medicinal plants, 17 were identified as true Mangrove (MNG), 24 as Mangrove Associates (MNA), and 57 as Non-Mangrove (NMG) species. Fabaceae (13 species) represented the leading family, followed by Lamiaceae and Compositae (5 species). Herbs (43%) have shown dominant life forms, and the leaves (41%) were frequently used plant parts. The most commonly cited preparation method was juice (24%), and the prevalent mode of administration was oral (62%). Azadirachta indica A. Juss. was the most widely used therapeutic plant species based on FC (39) values. The comparative literature review study reveals that the practices of 15 plants and their ethnomedicinal use by the Munda people are still entirely unexplored and newly reported in Bangladesh. Additionally, therapeutic use of 2 species, Brownlowia tersa (L.) Kosterm., and Dalbergia candenatensis (Dennst.) Prain has not been previously reported worldwide. In addition, 51 plant species (52%) of the total plants studied enlisted on the IUCN Red List of Threatened Species.
To our knowledge, this is the first ethnobotanical study on the Munda ethnic group in Bangladesh. This study indicates that Munda people still rely on medicinal plants for PHC and have a rich and varied traditional knowledge about the therapeutic use of plants. This study also warns of the high risk of the current availability status of plants in the study area. Therefore, this study calls for urgent steps to protect and conserve high-risk plants that can be done by taking both in-situ and ex-situ measures. In addition, further phytochemical and pharmacological investigations of the important medicinal plants cited in the study have been suggested.
在几乎每个社会的初级卫生保健(PHC)系统中,对药用植物的本土知识都是不可或缺的一部分。两百多年来,孟加拉国的一个少数民族——蒙达人一直生活在世界上最大的红树林——孙德尔本斯地区。这片红树林生物多样性丰富,但正受到全球气候变化的威胁。关于蒙达人少数民族利用植物进行治疗的信息仍然完全未知。因此,需要紧急记录。
本研究的目的是:(1)搜索和编纂蒙达人用于 PHC 需求的药用植物多样性数据;(2)对这些数据进行定量分析,以确定重要的药用植物和与该物种治疗相关的疾病。
我们对 79 名蒙达线人进行了多次实地调查和访谈,以收集民族植物学数据。通过随机抽样技术选择线人,并使用开放式和半结构化问卷进行访谈。我们以使用报告(UR)的形式报告主要(绝对)数据,并附有频率引用(FC)。遵循国际初级保健分类-2(ICPC-2)对药用植物的治疗用途进行分类,并使用 FC 和线人共识因子(ICF)进行定量分析。
本研究共探索和编纂了 3199 种用于治疗 132 种疾病的药用 UR,涉及 98 种药用植物,分为 16 种(16)ICPC-2 病理组。记录的 UR 中,消化系统(D)组最高(948 种),由 69 种植物治疗,其中社会问题(Z)疾病类别(ICF:1.00)的 ICF 值最高。记录的药用植物中,有 17 种被确认为真正的红树林(MNG),24 种为红树林伴生物种(MNA),57 种为非红树林物种(NMG)。豆科(13 种)是主要的科,其次是唇形科和菊科(5 种)。草本植物(43%)表现出优势的生活形态,叶片(41%)是常用的植物部位。最常用的制备方法是榨汁(24%),最常用的给药方式是口服(62%)。基于 FC(39)值,印楝(Azadirachta indica A. Juss.)是最广泛使用的治疗性植物物种。文献综述研究表明,蒙达人仍在使用 15 种植物及其民族医学用途,这些用途在孟加拉国仍完全未被探索,是新报道的。此外,Brownlowia tersa(L.)Kosterm.和 Dalbergia candenatensis(Dennst.)Prain 的治疗用途在世界范围内也从未有过报道。此外,在研究的总植物中,有 51 种植物(52%)被列入 IUCN 红色名录的濒危物种。
据我们所知,这是对孟加拉国蒙达人进行的第一项民族植物学研究。本研究表明,蒙达人仍依赖药用植物进行 PHC,他们拥有丰富多样的植物治疗传统知识。本研究还警告说,研究区域内植物目前的可利用状况存在很高的风险。因此,这项研究呼吁采取紧急措施保护和保存高风险的植物,可以通过就地和迁地措施来实现。此外,建议对研究中引用的重要药用植物进行进一步的植物化学和药理学研究。